RSS   Newsletter   Contact   Advertise with us
Post Online Media

Gelesis appoints two executives

GelesisGelesis, a biotechnology company, announced the appointment of David Pass as chief operating officer and William Aschenbach as vice president of medical affairs.
Dr. Pass joins Gelesis with more than 20 years of commercial expertise across multiple therapeutic areas with a focus on diabetes and metabolics.

Dr. Pass gained a broad range of commercial experience from his time with Johnson & Johnson, and Bristol-Myers Squibb.

Most recently, he served as Vice President of Marketing at Boehringer Ingelheim (BI) for Diabetes.

Dr. Aschenbach brings with him 13 years of diverse research and development and medical affairs experience from his tenure as Scientific Director of U.S. Medical Affairs for EMD Serono.

Dr. Aschenbach also previously served as the Director of Global Medical Research at Biogen Idec, where he led global external research and medical communications efforts for the company’s central nervous system franchise.


 LATEST MOVES FROM Massachusetts 


POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.